Th17 cells are defined by their capacity to produce IL-17, and are important mediators of inflammation and autoimmunity. Human Th17 cells express high levels of the retinoic acid-related orphan receptor variant 2 (RORC2), but it is currently unclear whether expression of this transcription factor alone is sufficient to recapitulate all the known properties of Th17 cells. We used lentivirus-mediated transduction to investigate the role of RORC2 in defining aspects of the human Th17 cell lineage. Expression of RORC2 induced production of IL-17A, IL-22, IL-6 and TNF-a, a Th17-cell-associated chemokine receptor profile and upregulation of CD161. RORC2-transduced T cells were hypo-responsive to TCR-mediated stimulation, a property shared with ex vivo Th17 cells and overcome by addition of exogenous IL-2 or IL-15. Co-culture experiments revealed that RORC2-expressing cells were partially resistant to Treg cells since production of IL-17 and proliferation were not suppressed. Evidence that IL-17 stimulates CD41 T cells to produce IL-2 and proliferate suggested that the resistance of Th17 cells to Treg-mediated suppression may be partly attributed to IL-17 itself. These findings demonstrate that expression of RORC2 in T cells has functional consequences beyond altering cytokine production and provides insight into the factors regulating the development of human Th17 cells. 2]. More recently, a Th-cell lineage defined by its capacity to secrete IL-17 (Th17 cells) has been identified [3][4][5]. Mouse models have demonstrated that Th17 cells are critical for host defense against extracellular pathogens [6,7], whereas their aberrant expansion is linked to the pathogenesis of inflammatory autoimmune disorders [8]. Although Th17 cells produce several inflammatory cytokines, many of their effector functions are attributed to IL-17 production. IL-17 is known to recruit neutrophils and stimulate the production of pro-inflammatory cytokines, chemokines and antimicrobial peptides from a variety of immune and nonimmune cells [8][9][10][11]. Evidence from studies documenting increased levels of IL-17 in the peripheral blood and tissues of patients with rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease [12][13][14], and experimental models demonstrating a clear role for Th17 cells in the pathogenesis of these diseases, suggests that strategies to inhibit the
1480differentiation and/or function of Th17 cells in vivo may result in new therapies for inflammatory and autoimmune diseases.Most of the current knowledge regarding the phenotype and function of Th17 cells is based on studies carried out in mice. Mouse Th17 cells are defined by their capacity to produce IL-17 (IL-17A), IL-17F, TNF-a, IL-6 and IL-22, but not [15][16][17]. In vitro, TGF-b1 and IL-6 polarize naive mouse CD4 1 T cells into Th17 cells [18][19][20], whereas IL-23 is thought to be important for their expansion, survival, effector function and pathogenicity in vivo [20,21,22]. At the molecular level, at least five transcription factors are invol...